Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Human Plasma-Derived Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Human Plasma-Derived Therapeuticsmarket, defines the market attractiveness level of Human Plasma-Derived Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Human Plasma-Derived Therapeutics industry, describes the types of Human Plasma-Derived Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Human Plasma-Derived Therapeutics market and the development prospects and opportunities of Human Plasma-Derived Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Human Plasma-Derived Therapeutics market in Chapter 13.
By Player:
Entegrion, Inc
Gammagard
Shire
Prometic Life Sciences
CSL Behring
Kedrion
Grifols
Sanquin
Alkahest
Baxter
Octapharma
By Type:
Albumin
Immunoglobulin
Clotting Factor
Prothrombin Complex
Others
By End-User:
Hospital
Clinic
Research Center
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Human Plasma-Derived Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Human Plasma-Derived Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Human Plasma-Derived Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Human Plasma-Derived Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Human Plasma-Derived Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Human Plasma-Derived Therapeutics Consumption (2017-2022)
-
7.2 United States Human Plasma-Derived Therapeutics Consumption (2017-2022)
-
7.3 Europe Human Plasma-Derived Therapeutics Consumption (2017-2022)
-
7.4 China Human Plasma-Derived Therapeutics Consumption (2017-2022)
-
7.5 Japan Human Plasma-Derived Therapeutics Consumption (2017-2022)
-
7.6 India Human Plasma-Derived Therapeutics Consumption (2017-2022)
-
7.7 South Korea Human Plasma-Derived Therapeutics Consumption (2017-2022)
8 Region and Country-wise Human Plasma-Derived Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Human Plasma-Derived Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Human Plasma-Derived Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Human Plasma-Derived Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Human Plasma-Derived Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Human Plasma-Derived Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Human Plasma-Derived Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Human Plasma-Derived Therapeutics Consumption Forecast (2022-2028)
9 Global Human Plasma-Derived Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Human Plasma-Derived Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Albumin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Immunoglobulin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Clotting Factor Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Prothrombin Complex Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Human Plasma-Derived Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Center Consumption and Growth Rate (2017-2022)
10 Global Human Plasma-Derived Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Human Plasma-Derived Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Albumin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Clotting Factor Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Prothrombin Complex Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Human Plasma-Derived Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Research Center Consumption Forecast and Growth Rate (2022-2028)
11 Global Human Plasma-Derived Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Human Plasma-Derived Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Human Plasma-Derived Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Human Plasma-Derived Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Human Plasma-Derived Therapeutics Market Competitive Analysis
-
14.1 Entegrion, Inc
-
14.1.1 Entegrion, Inc Company Details
-
14.1.2 Entegrion, Inc Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Entegrion, Inc Human Plasma-Derived Therapeutics Product and Service
-
14.2 Gammagard
-
14.2.1 Gammagard Company Details
-
14.2.2 Gammagard Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Gammagard Human Plasma-Derived Therapeutics Product and Service
-
14.3 Shire
-
14.3.1 Shire Company Details
-
14.3.2 Shire Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Shire Human Plasma-Derived Therapeutics Product and Service
-
14.4 Prometic Life Sciences
-
14.4.1 Prometic Life Sciences Company Details
-
14.4.2 Prometic Life Sciences Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Prometic Life Sciences Human Plasma-Derived Therapeutics Product and Service
-
14.5 CSL Behring
-
14.5.1 CSL Behring Company Details
-
14.5.2 CSL Behring Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 CSL Behring Human Plasma-Derived Therapeutics Product and Service
-
14.6 Kedrion
-
14.6.1 Kedrion Company Details
-
14.6.2 Kedrion Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Kedrion Human Plasma-Derived Therapeutics Product and Service
-
14.7 Grifols
-
14.7.1 Grifols Company Details
-
14.7.2 Grifols Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Grifols Human Plasma-Derived Therapeutics Product and Service
-
14.8 Sanquin
-
14.8.1 Sanquin Company Details
-
14.8.2 Sanquin Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sanquin Human Plasma-Derived Therapeutics Product and Service
-
14.9 Alkahest
-
14.9.1 Alkahest Company Details
-
14.9.2 Alkahest Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Alkahest Human Plasma-Derived Therapeutics Product and Service
-
14.10 Baxter
-
14.10.1 Baxter Company Details
-
14.10.2 Baxter Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Baxter Human Plasma-Derived Therapeutics Product and Service
-
14.11 Octapharma
-
14.11.1 Octapharma Company Details
-
14.11.2 Octapharma Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Octapharma Human Plasma-Derived Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Human Plasma-Derived Therapeutics
-
Figure Human Plasma-Derived Therapeutics Picture
-
Table Global Human Plasma-Derived Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Plasma-Derived Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Plasma-Derived Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Human Plasma-Derived Therapeutics Consumption by Country (2017-2022)
-
Figure United States Human Plasma-Derived Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Human Plasma-Derived Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Human Plasma-Derived Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Human Plasma-Derived Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Human Plasma-Derived Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Human Plasma-Derived Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Human Plasma-Derived Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Human Plasma-Derived Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Human Plasma-Derived Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Human Plasma-Derived Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Human Plasma-Derived Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Human Plasma-Derived Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Human Plasma-Derived Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Albumin Consumption and Growth Rate (2017-2022)
-
Figure Global Immunoglobulin Consumption and Growth Rate (2017-2022)
-
Figure Global Clotting Factor Consumption and Growth Rate (2017-2022)
-
Figure Global Prothrombin Complex Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Research Center Consumption and Growth Rate (2017-2022)
-
Figure Global Albumin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clotting Factor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prothrombin Complex Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Center Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Human Plasma-Derived Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Human Plasma-Derived Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Entegrion, Inc (Foundation Year, Company Profile and etc.)
-
Table Entegrion, Inc Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Entegrion, Inc Human Plasma-Derived Therapeutics Product and Service
-
Table Gammagard (Foundation Year, Company Profile and etc.)
-
Table Gammagard Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gammagard Human Plasma-Derived Therapeutics Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Human Plasma-Derived Therapeutics Product and Service
-
Table Prometic Life Sciences (Foundation Year, Company Profile and etc.)
-
Table Prometic Life Sciences Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Prometic Life Sciences Human Plasma-Derived Therapeutics Product and Service
-
Table CSL Behring (Foundation Year, Company Profile and etc.)
-
Table CSL Behring Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Behring Human Plasma-Derived Therapeutics Product and Service
-
Table Kedrion (Foundation Year, Company Profile and etc.)
-
Table Kedrion Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kedrion Human Plasma-Derived Therapeutics Product and Service
-
Table Grifols (Foundation Year, Company Profile and etc.)
-
Table Grifols Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Human Plasma-Derived Therapeutics Product and Service
-
Table Sanquin (Foundation Year, Company Profile and etc.)
-
Table Sanquin Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanquin Human Plasma-Derived Therapeutics Product and Service
-
Table Alkahest (Foundation Year, Company Profile and etc.)
-
Table Alkahest Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alkahest Human Plasma-Derived Therapeutics Product and Service
-
Table Baxter (Foundation Year, Company Profile and etc.)
-
Table Baxter Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Human Plasma-Derived Therapeutics Product and Service
-
Table Octapharma (Foundation Year, Company Profile and etc.)
-
Table Octapharma Human Plasma-Derived Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Octapharma Human Plasma-Derived Therapeutics Product and Service
-
